Drug

Massive Study Flips Our Story of Addiction and the Brain Brain differences in children and teens who experiment with drugs early show up before they take their first puff or …

Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Novartis has won approval in Switzerland for the world’s first …

Fidson Healthcare is putting up equity financing for consideration at its annual meeting of shareholders this month, hoping to secure a key approval for an additional capital raise of N30 …

Putting the brakes on an enzyme might rescue neurons that are dying due to a type of Parkinson’s disease that’s caused by a single genetic mutation, according to a new …

A Federal High Court in Lagos has sentenced four individuals, two Nigerians and two Beninoise, to five years imprisonment each for smuggling 5.622 kilograms of cocaine across the Seme Border …

Fergus Walsh Medical Editor BBC Mary Catchpole is the first person to benefit from a new treatment for a rare condition affecting her family A teenager from Norfolk has become …

Penn-led researchers have turned a deadly fungus into a potent cancer-fighting compound. After isolating a new class of molecules from Aspergillus flavus, a toxic crop fungus linked to deaths in …

Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Novo Nordisk’s new injectable obesity drug has the potential to …

Topline Yeztugo, a twice-a-year antiviral shot to prevent HIV, was approved by the Food and Drug Administration on Wednesday, marking a major advance in battling AIDS. Yeztugo was approved by …

Law enforcement authorities from six countries took down the Archetyp Market, an infamous darknet drug marketplace that has been operating since May 2020. Archetyp Market sellers provided the market’s customers …